Celldex Therapeutics to present poster on its first antibody-drug conjugate product

[News]

Celldex Therapeutics, Inc. today announced that the Company’s first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.

More... (http://www.news-medical.net/news/20091208/Celldex-Therapeutics-to-present-poster-on-its-first-antibody-drug-conjugate-product.aspx)